[Use of rocuronium in a pateint with myasthenia gravis].
Palop Manjón-Cabeza
E
E
Cervera
S
S
Ramírez
A
A
Almazán
A
A
D000732:Androstanols / Q000493:pharmacokinetics; D000762:Anesthesia Recovery Period; D006207:Half-Life; D006801:Humans; D007430:Intraoperative Care; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000493:pharmacokinetics; D011182:Postoperative Care; D000077123:Rocuronium; D013934:Thymectomy; D013953:Thymus Neoplasms / Q000150:complications / Q000601:surgery*
D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D000077123:Rocuronium